GALECTIN THERAPEUTICS INC — Investor Relations & Filings
Filings indexed
1,091
across all filing types
Latest filing
2018-06-13
Director's Dealing
Country
US
United States of America
Listing
US
GALT
Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2018 | 2018-06-13 | English | |
| PRIMARY DOCUMENT | 2018-06-12 | English | |
| PRIMARY DOCUMENT | 2018-06-12 | English | |
| PRIMARY DOCUMENT | 2018-06-12 | English | |
| FORM 8-K | 2018-06-12 | English | |
| PRIMARY DOCUMENT | 2018-06-08 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 11421496 | Director's Dealing 2018 | 2018-06-13 | English | ||
| 11421497 | PRIMARY DOCUMENT | 2018-06-12 | English | ||
| 11421498 | PRIMARY DOCUMENT | 2018-06-12 | English | ||
| 11421500 | PRIMARY DOCUMENT | 2018-06-12 | English | ||
| 11421499 | FORM 8-K | 2018-06-12 | English | ||
| 11421501 | PRIMARY DOCUMENT | 2018-06-08 | English | ||
| 11421502 | PRIMARY DOCUMENT | 2018-06-06 | English | ||
| 11421503 | Director's Dealing 2018 | 2018-06-05 | English | ||
| 11421504 | Director's Dealing 2018 | 2018-06-05 | English | ||
| 11421505 | PRIMARY DOCUMENT | 2018-06-04 | English | ||
| 11421506 | PRIMARY DOCUMENT | 2018-06-04 | English | ||
| 11421507 | PRIMARY DOCUMENT | 2018-05-29 | English | ||
| 11421508 | PRIMARY DOCUMENT | 2018-05-29 | English | ||
| 11421509 | 8-K | 2018-05-29 | English | ||
| 11421510 | PRIMARY DOCUMENT | 2018-05-24 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GALECTIN THERAPEUTICS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33422/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33422 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33422 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33422 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33422}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GALECTIN THERAPEUTICS INC (id: 33422)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.